Cite
HARVARD Citation
Short, N. et al. (2022). Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD‐negative remission. American journal of hematology. 97 (11), pp. E408-E411. [Online].